Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Clinical & Translational Immunology|March 20, 2023
Cerebrospinal fluid YKL-40 level evolution is associated with autoimmune encephalitis remissionGuillaume Dorcet, Marie Benaiteau, Jérémie Pariente, et al.Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|August 1, 2025
Caregivers' perspectives on long-term cognitive, psychiatric, psychological, and social outcomes in NMDAR encephalitis: Initial findings from the multi-center prospective SAPIENCE studyMarta Duda-Sikuła, Ole Jonas Boeken, Víctor Patricio, et al.BMC Neurology|November 14, 2025
Managing paraneoplastic GABABR-related limbic encephalitis in a patient with a small cell lung cancer receiving an Immune-Checkpoint Inhibitor (ICI) therapy: description of a case reportMathilde Cezar, Rachele Belletto, Sara Polidori, et al.Journal of Alzheimer'S Disease : JAD|August 16, 2021
Taking the A Train? Limited Consistency of Aβ42 and the Aβ42/40 Ratio in the AT(N) ClassificationDominique Gouilly, Camille Tisserand, Leonor Nogueira, et al.Neurology(R) Neuroimmunology & Neuroinflammation|July 18, 2025
Immune Checkpoint Inhibitors Trigger and Exacerbate Anti-CV2/CRMP5 Paraneoplastic Neurologic SyndromesGiulia Sofia Cereda, Macarena Villagrán-García, Antonio Farina, et al.BMC Neurology|September 6, 2024
Assessment of long-term psychosocial outcomes in N-methyl-D-aspartate receptor encephalitis - the SAPIENCE study protocolOle Jonas Boeken, Josephine Heine, Marta Duda-Sikula, et al.Journal for Immunotherapy of Cancer|June 24, 2026
Immune checkpoint inhibitor neurotoxicity: long-term outcomes with focus on 1-year neurological sequelaeAntonio Farina, Macarena Villagrán-García, Amna Abichou-Klich, et al.Journal of Neurology|March 12, 2024
Neurological autoimmunity in melanoma patients: a comparison between those exposed and non-exposed to immune checkpoint inhibitorsAndreu Vilaseca, Antonio Farina, Macarena Villagrán-García, et al.Neurology(R) Neuroimmunology & Neuroinflammation|October 8, 2025
Serum Neurofilament Light Chain Correlates With Clinical Severity and Predicts Mortality in Anti-IgLON5 DiseaseAntonio Farina, Macarena Villagrán-García, Amna Abichou-Klich, et al.Journal of Neurology|March 18, 2024
Dysautonomia in anti-Hu paraneoplastic neurological syndromesMacarena Villagrán-García, Antonio Farina, Joaquín Arzalluz-Luque, et al.Pageof 4